- Report
- June 2022
- 55 Pages
India
From €4750EUR$5,000USD£4,086GBP
- Report
- January 2022
- 42 Pages
Global
From €3563EUR$3,750USD£3,065GBP
- Report
- March 2019
- 168 Pages
Global
From €1306EUR$1,375USD£1,124GBP
€2613EUR$2,750USD£2,247GBP
- Report
- April 2018
- 159 Pages
Global
From €594EUR$625USD£511GBP
€1188EUR$1,250USD£1,022GBP
From €4275EUR$4,500USD£3,678GBP
- Report
- May 2024
- 100 Pages
From €3605EUR$3,795USD£3,101GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
- Report
- April 2024
- 80 Pages
From €2465EUR$2,595USD£2,121GBP
The NAT Screening market within the context of In Vitro Diagnostics is a segment of the healthcare industry that focuses on the development and commercialization of tests that detect the presence of infectious agents in a sample. These tests are used to diagnose and monitor the spread of infectious diseases, such as HIV, hepatitis, and other viruses. NAT Screening tests are used in a variety of settings, including clinical laboratories, hospitals, and public health departments.
NAT Screening tests are typically performed using a variety of technologies, such as polymerase chain reaction (PCR), nucleic acid hybridization, and enzyme-linked immunosorbent assays (ELISA). These tests are used to detect the presence of specific genetic material in a sample, which can be used to identify the presence of a particular infectious agent.
Some companies in the NAT Screening market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more